InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Hopfner Robert Lorne, Director. Director active across 2 companies, notably Rallybio Corp. Aggregated, 3 filings have been recorded. Total volume traded: €3.7m. The latest transaction was disclosed on 19 April 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€4m1,070,000 shares@ €3.4184100.0% of flow
Common Stock
SEC:0001209191-22-024919:0·
Ideal exit: 14 Jan 2023 (T+270)
1,694,388 shares
Common Stock
SEC:0000899243-21-031635·
1,694,388 shares
Common Stock
SEC:0000899243-21-031635:0·
3 of 3 declarations
About Hopfner Robert Lorne
Robert Lorne Hopfner is a Board Member at Rallybio Corp and Inozyme Pharma, Inc. He brings expertise in corporate governance and strategy. Robert is involved in key decisions that influence the direction and performance of these companies.
